Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
Investment Firms›
UTokyo Innovation Platform
AddedFeb 15, 2024
UpdatedJun 28, 2026
UTokyo Innovation Platform

UTokyo Innovation Platform

Operating

University of Tokyo IPC: Accelerating global innovation through startup support, investment, and corporate innovation since 2016.

Location
Tokyo, Tokyo, JP
Founded
2016
Firm
Compare
Portfolio
Employees
Website

UTokyo Innovation Platform focuses on accelerating global innovation through investments in early-stage startups, particularly those emerging from the University of Tokyo ecosystem. As a wholly-owned subsidiary of the University of Tokyo, the firm primarily targets Series A rounds, with occasional participation in later stages. Their investment strategy spans various sectors, with a notable emphasis on biotechnology and life sciences.

The firm's portfolio includes promising companies such as Axial Therapeutics, Carbon Biosciences, and DEM Biopharma, all of which have raised significant capital. UTokyo Innovation Platform offers comprehensive support to startups, including investment, mentorship, and access to the university's vast research resources. Their unique position as a university-affiliated investor allows them to bridge academic research with commercial applications, fostering innovation and global competitiveness.

UTokyo Innovation Platform - Portfolio Snapshot

Portfolio activity breakdown across disclosed investments and stages

Total Investments4
Current Portfolio Count4
Total Portfolio Exits0

Top Investment Stages

Series A2 (50.0%)
Series C1 (25.0%)
Series Unknown1 (25.0%)

Stage Mix

Series A 50%Series C 25%Series Unknown 25%

Concentration shown as share of disclosed investments by stage.

Recent Investments

QSimulate logo

QSimulate

DEM Biopharma logo

DEM Biopharma

Carbon Biosciences logo

Carbon Biosciences

Axial Therapeutics logo

Axial Therapeutics

UTokyo Innovation Platform - Similar Investment Firms

Utec logo

Utec

ut-ec.co.jp

Kyoto University Innovation Capital logo

Kyoto University Innovation Capital

kyoto-unicap.co.jp

JR East Start Up logo

JR East Start Up

jrestartup.co.jp

JIC Venture Growth Investments logo

JIC Venture Growth Investments

Tohoku University Venture Partners logo

Tohoku University Venture Partners

thvp.co.jp

Neoteny logo

Neoteny

neoteny.com

TechU Ventures logo

TechU Ventures

for Startups logo

for Startups

forstartups.com

UF Innovate Ventures logo

UF Innovate Ventures

Hitotoki Incubator logo

Hitotoki Incubator

hitotoki.in

Yakumi logo

Yakumi

yakumi.co

Movida Japan logo

Movida Japan

Miyako Capital logo

Miyako Capital

miyakocapital.com

UCL Technology Fund logo

UCL Technology Fund

ucltf.co.uk

01Booster logo

01Booster

01booster.com

UTokyo Innovation Platform - Classification

Also Known As
  • UTokyo Innovation Platform Co., Ltd.
NAICS
  • 520000Finance and Insurance
  • 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
  • 523900Other Financial Investment Activities
  • 523990All Other Financial Investment Activities
  • 523999Miscellaneous Financial Investment Activities
SIC
  • 7300Business Services
Show 2 more industry codes
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541000Professional, Scientific, and Technical Services